SYNAPS Dx Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

  • Investors
  • 1

SYNAPS Dx General Information

Description

Developer of an Alzheimer's disease diagnostic tool designed to commercialize the biomarker technology. The company researches, develops, and commercializes diagnostics for neurodegenerative disorders and conditions, enabling healthcare professionals with the necessary scientific data to identify Alzheimer's Disease and distinguish it from other dementias.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12441 Parklawn Drive
  • Suite 2A
  • Rockville, MD 20852
  • United States
+1 (301)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 12441 Parklawn Drive
  • Suite 2A
  • Rockville, MD 20852
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SYNAPS Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series A) 13-Oct-2021 $10M Completed Generating Revenue
To view SYNAPS Dx’s complete valuation and funding history, request access »

SYNAPS Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view SYNAPS Dx’s complete cap table history, request access »

SYNAPS Dx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an Alzheimer's disease diagnostic tool designed to commercialize the biomarker technology. The company rese
Diagnostic Equipment
Rockville, MD
19 As of 2026

Lexington, MA
 

Cincinnati, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SYNAPS Dx Competitors (23)

One of SYNAPS Dx’s 23 competitors is T2 Biosystems, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
T2 Biosystems Formerly VC-backed Lexington, MA
Meridian Bioscience Private Equity-Backed Cincinnati, OH
Optina Diagnostics Venture Capital-Backed Montreal, Canada
RetiSpec Venture Capital-Backed Toronto, Canada
Cepheid Formerly VC-backed Sunnyvale, CA
You’re viewing 5 of 23 competitors. Get the full list »

SYNAPS Dx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SYNAPS Dx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Semler Scientific Corporation Minority
To view SYNAPS Dx’s complete investors history, request access »

SYNAPS Dx FAQs

  • When was SYNAPS Dx founded?

    SYNAPS Dx was founded in 2016.

  • Where is SYNAPS Dx headquartered?

    SYNAPS Dx is headquartered in Rockville, MD.

  • What is the size of SYNAPS Dx?

    SYNAPS Dx has 19 total employees.

  • What industry is SYNAPS Dx in?

    SYNAPS Dx’s primary industry is Diagnostic Equipment.

  • Is SYNAPS Dx a private or public company?

    SYNAPS Dx is a Private company.

  • What is the current valuation of SYNAPS Dx?

    The current valuation of SYNAPS Dx is .

  • What is SYNAPS Dx’s current revenue?

    The current revenue for SYNAPS Dx is .

  • How much funding has SYNAPS Dx raised over time?

    SYNAPS Dx has raised $10M.

  • Who are SYNAPS Dx’s investors?

    Semler Scientific has invested in SYNAPS Dx.

  • Who are SYNAPS Dx’s competitors?

    T2 Biosystems, Meridian Bioscience, Optina Diagnostics, RetiSpec, and Cepheid are some of the 23 competitors of SYNAPS Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process